Diabetes Technology and Therapeutics : Impact Factor & More
eISSN: 1557-8593pISSN: 1520-9156
Share this on:
Key Metrics
CiteScore 
10.3
Eigenfactor
0.005 - 0.01
H-Index
97
Impact Factor
5 - 10
SJR
Q1Endocrinology
SNIP
1.97
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Diabetes Technology and Therapeutics
Diabetes Technology and Therapeutics Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Diabetes Technology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Diabetes Technology and Therapeutics
Automated Insulin Delivery System Initiation Safely Improves Glycemic Outcomes in Older Adults with Type 1 Diabetes.
- 3 Aug 2026
- Diabetes technology & therapeutics
Ensuring Equitable Access to Diabetes Technology for People with Disabilities.
- 31 Jul 2026
- Diabetes technology & therapeutics
Perioperative Blood Glucose Control following Implementation of Standardized Protocols in Children and Adolescents with Diabetes Undergoing Surgery.
- 30 Jul 2026
- Diabetes technology & therapeutics
Continuous Glucose Monitoring Metrics in Women with Type 2 Diabetes in Pregnancy: The TIMELY Observational Cohort Study.
- 21 Jul 2026
- Diabetes technology & therapeutics
Evaluation of an Objective Measure of Mealtime Insulin Administration Frequency in Emerging Adults with Type 1 Diabetes.
- 17 Jul 2026
- Diabetes technology & therapeutics
Three-Year Durability of Automated Insulin Delivery Therapy in Children and Adolescents with Type 1 Diabetes: A Multicenter Real-World Study.
- 17 Jul 2026
- Diabetes technology & therapeutics
Automated Insulin Delivery System Initiation Safely Improves Glycemic Outcomes in Older Adults with Type 1 Diabetes.
- 3 Aug 2026
- Diabetes technology & therapeutics
Ensuring Equitable Access to Diabetes Technology for People with Disabilities.
- 31 Jul 2026
- Diabetes technology & therapeutics
Perioperative Blood Glucose Control following Implementation of Standardized Protocols in Children and Adolescents with Diabetes Undergoing Surgery.
- 30 Jul 2026
- Diabetes technology & therapeutics
Continuous Glucose Monitoring Metrics in Women with Type 2 Diabetes in Pregnancy: The TIMELY Observational Cohort Study.
- 21 Jul 2026
- Diabetes technology & therapeutics
Evaluation of an Objective Measure of Mealtime Insulin Administration Frequency in Emerging Adults with Type 1 Diabetes.
- 17 Jul 2026
- Diabetes technology & therapeutics
Three-Year Durability of Automated Insulin Delivery Therapy in Children and Adolescents with Type 1 Diabetes: A Multicenter Real-World Study.
- 17 Jul 2026
- Diabetes technology & therapeutics
FAQs on Diabetes Technology and Therapeutics
How long has Diabetes Technology and Therapeutics been actively publishing? 
What is the publishing frequency of Diabetes Technology and Therapeutics?
How many articles did Diabetes Technology and Therapeutics publish last year?
What is the eISSN & pISSN for Diabetes Technology and Therapeutics?
What is Citescore for Diabetes Technology and Therapeutics?
What is the H Index for Diabetes Technology and Therapeutics ?
What is SNIP score for Diabetes Technology and Therapeutics?
What is the SJR for Diabetes Technology and Therapeutics?
Who is the publisher of Diabetes Technology and Therapeutics?
